Atrium plans to move headquarters to larger Merrimack, NH facility

HUDSON, N.H., April 26, 2012 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, announced today that it plans to relocate its company headquarters to a newly purchased site in Merrimack, NH to accommodate the company's exponential growth over the last few years. The current facility located in Hudson, NH has been the corporate headquarters for the last 17 years, but has reached its expansion limits and can no longer support the company's growth demands. 

The property at 40 Continental Boulevard in Merrimack, NH offers a newly renovated 115,000 square foot two-story structure and will be expanded to include an additional 90,000 square foot state-of-the-art medical manufacturing and R&D facility. The new campus will provide the resources and space necessary for Atrium's growing family of talented and dedicated employees as they continue their mission of excellence.

"Our company has grown tremendously over the last few years and is projected to continue expanding in the years to come. Therefore, it is necessary for us to relocate our headquarters to a facility that will meet the needs of our employees and customers in the future," said Trevor Carlton, President, Atrium Medical Corporation. "Moving our headquarters also allows us the opportunity to continue collaborating with leading clinicians and researchers from around the world to meet the demands for expansive evidence-based clinical trials that can lead to important med-tech discoveries with the ultimate goal of improving patient outcomes."  

"This investment is affirmation of MAQUET's commitment to developing world class, minimally invasive medical products that have a positive impact on both patient care and health economics and is an acknowledgement of the expertise, innovativeness and dedication of the Atrium organization", stated Christian Keller, President and CEO of MAQUET Cardiovascular.

Atrium currently employs approximately 450 people in its existing facility in Hudson, with plans to expand to 700 over the next several years. The company has been based in Southern New Hampshire since its inception more than 31 years ago.

About Atrium Medical Corporation

Atrium Medical Corporation's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Maintaining a commitment to the latest ISO13485 Quality Standards, state-of-the-art manufacturing and automation, cell biology and biomaterial discovery programs, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for improvements in patient outcomes. Atrium is a business unit of MAQUET Cardiovascular, a member of the GETINGE GROUP of companies. For more information please visit www.atriummed.com.

About MAQUET

As a trusted partner for hospitals and clinicians since 1838, MAQUET is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. MAQUET develops and designs innovative products and therapeutic applications for the operating room, hybrid OR/cath lab, intensive care unit and patient transport within acute care hospitals, improving outcomes and quality of life for patients.

Cardiovascular specialties include intra-aortic balloon counterpulsation (IABC) therapy for cardiac assist; coronary artery bypass surgery; aortic and peripheral vascular surgery; and extracorporeal circulation.

The Critical Care portfolio includes market-leading intensive care ventilators and anesthesia machines.

MAQUET also equips Surgical Workplaces with critical infrastructure such as flexible room design for OR and ICU; OR tables; lights and ceiling supply units; and OR integration for image data management.

MAQUET is a subsidiary of the publicly listed Swedish GETINGE GROUP. In 2011, MAQUET generated nearly 1.4 billion Euro which is more than half of the Group's annual revenue of 2.4 billion Euros. The GETINGE Group has 13,000 employees worldwide, including around 6,000 MAQUET employees in 50 international sales and service organizations, as well as a network of more than 280 sales representatives. For more information please visit www.maquet.com and www.getingegroup.com.

SOURCE Atrium Medical Corporation